Amprion (Biotechnology) Overview
- Year Founded
-
2007
- Status
-
Private
- Employees
-
37
- Latest Deal Type
-
General Corporate Purpose
- Investors
-
9
Amprion (Biotechnology) General Information
Description
Developer of a test designed to detect pathological α-synuclein in cerebrospinal fluid. The company offers a laboratory-developed biomarker test that detects pathogenic misfolded proteins through seed amplification technology, enabling healthcare providers and clinical laboratories to improve diagnostic accuracy for neurodegenerative diseases.
Contact Information
Website
www.ampriondx.comCorporate Office
- 149 New Montgomery Street
- 4th Floor
- San Francisco, CA 94105
- United States
Corporate Office
- 149 New Montgomery Street
- 4th Floor
- San Francisco, CA 94105
- United States
Amprion (Biotechnology) Timeline
Amprion (Biotechnology) Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 12. General Corporate Purpose | 08-Jul-2026 | Completed | Generating Revenue | |||
| 11. PE Growth/Expansion | 08-Jul-2026 | Announced | Generating Revenue | |||
| 10. Later Stage VC | Completed | Generating Revenue | ||||
| 9. Later Stage VC (Series B) | 09-Oct-2024 | Completed | Generating Revenue | |||
| 8. Grant | 01-Jan-2023 | Completed | Generating Revenue | |||
| 7. Later Stage VC (Series A) | 15-Jul-2022 | Completed | Generating Revenue | |||
| 6. Grant | 01-May-2021 | Completed | Generating Revenue | |||
| 5. Grant | 01-Jan-2019 | Completed | Generating Revenue | |||
| 4. Grant | 01-Apr-2018 | $618K | Completed | Generating Revenue | ||
| 3. Grant | 01-Jan-2017 | $1.71M | Completed | Generating Revenue |
Amprion (Biotechnology) Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-3 | ||||||||
| Series A-2 | ||||||||
| Series A-1 | 206,228 | $0.001000 | $24.51 | $24.51 | 1x | $24.51 | 2.63% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Amprion (Biotechnology) Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Amprion (Biotechnology) Patents
Amprion (Biotechnology) Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026213448-A1 | Method for purification of full length tau and tau fragments for use in seed amplification assays | Pending | 02-Apr-2025 | ||
| WO-2026165436-A1 | Capture of misfolded protein aggregates by beads bound to an amyloid-binding dye. | Pending | 30-Jan-2025 | ||
| CA-3232289-A1 | Inert matrices for qualitative and semi-quantitative seed amplification assays | Pending | 13-Sep-2021 | ||
| EP-4402164-A1 | Inert matrices for qualitative and semi-quantitative seed amplification assays | Pending | 13-Sep-2021 | ||
| EP-4402164-A4 | Inert matrices for qualitative and semi-quantitative seed amplification assays | Pending | 13-Sep-2021 | C07K14/765 |
Amprion (Biotechnology) Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Amprion (Biotechnology) Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Eli Lilly and Company Foundation | Limited Partner | Minority | ||
| Formation Venture Engineering | Venture Capital | Minority | ||
| Snatched Ventures | Venture Capital | Minority | ||
| Alzheimers Drug Discovery Foundation | Not-For-Profit Venture Capital | |||
| Angel (individual) | Minority |
Amprion (Biotechnology) FAQs
-
When was Amprion (Biotechnology) founded?
Amprion (Biotechnology) was founded in 2007.
-
Where is Amprion (Biotechnology) headquartered?
Amprion (Biotechnology) is headquartered in San Francisco, CA.
-
What is the size of Amprion (Biotechnology)?
Amprion (Biotechnology) has 37 total employees.
-
What industry is Amprion (Biotechnology) in?
Amprion (Biotechnology)’s primary industry is Biotechnology.
-
Is Amprion (Biotechnology) a private or public company?
Amprion (Biotechnology) is a Private company.
-
What is Amprion (Biotechnology)’s current revenue?
The current revenue for Amprion (Biotechnology) is .
-
How much funding has Amprion (Biotechnology) raised over time?
Amprion (Biotechnology) has raised $17.1M.
-
Who are Amprion (Biotechnology)’s investors?
Eli Lilly and Company Foundation, Formation Venture Engineering, Snatched Ventures, Alzheimers Drug Discovery Foundation, and are 5 of 9 investors who have invested in Amprion (Biotechnology).
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
